Computer Vision News - January 2022

55 FemTherapeutics software packages, such as Abaqus and Ansys. ” Negin continues: “ The second part uses  supervised learning . When we have the patient data, there will be some parameters defined by the software based on the information obtained from the doctors. We fit them into the design and then we use AI – some basic Neural Networks – to run through the parameters and output the best parameters of all to create the most optimal design for that particular patient. ” FemTherapeutics is now 11 people covering business, marketing, technical, and medical. Its funding is non-dilutive and what it does have has come from government grants, Mitacs projects, competitions, and regular applications to bring in further funding from other sources. The team have set themselves quite a task with many problems to solve, including design, production, regulation, and distribution. As a scientist, is Negin prepared for all the challenges this new venture is going to entail? “ That’s a good point! ” she laughs. “ But we have been working on this for two and a half years now and are fortunate enough to have lots of resources behind us. We did two accelerations where we met with other CEOs, scientists, and entrepreneurs and explored how they overcame these problems, particularly in the MedTech sector, which is more difficult because of the regulations and certifications involved. You have to be ready for it to take at least three or four years to get to market. ” There is no doubt Negin and the team have done their homework and are very well placed to bring this project to market. But with so much at stake, has she thought about what might go wrong? “ Everything! ” she jokes. “ No, I hope nothing, but we have to be prepared for anything. There is very limited data in the MedTech sector. People are resistant of AI, especially doctors. They don’t know what they’re looking at. It’s like a black box. They don’t relate to it. We have a lot of explaining to do to get the data we need. ” Another issue they have is access to data from hospitals and clinics image from sketchfab.com